| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
126,890,000 |
| Market
Cap: |
1.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.82 - $9.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies for blood-related cancers where there is an unmet medical need. Co. has one commercially approved product, VONJO™ (pacritinib), which has received approval in the U.S. by the U.S. Food and Drug Administration for the treatment of adult patients with intermediate or primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 x 10^9/L.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
5,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$27,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
9,922,851 |
| Total Sell Value |
$0 |
$0 |
$0 |
$60,660,378 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
29 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Singer Jack W |
EVP, Global Medical Affairs |
• • – |
2015-05-22 |
4 |
AS |
$1.73 |
$26,045 |
D/D |
(15,000) |
1,305,919 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2015-05-21 |
4 |
AS |
$1.80 |
$18,000 |
D/D |
(10,000) |
935,416 |
|
- |
|
| Plunkett Matthew |
EVP, Corporate Development |
• – – |
2015-05-04 |
4 |
AS |
$1.85 |
$18,553 |
D/D |
(10,000) |
701,740 |
|
- |
|
| Baxter Healthcare Sa |
10% Owner |
– – • |
2015-04-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,673,981) |
0 |
|
- |
|
| Singer Jack W |
EVP, Global Medical Affairs |
• • – |
2015-04-24 |
4 |
AS |
$1.94 |
$29,443 |
D/D |
(15,000) |
1,320,919 |
|
- |
|
| Bianco Louis A |
EVP,Finance and Administration |
• – – |
2015-04-23 |
4 |
AS |
$1.93 |
$19,300 |
D/D |
(10,000) |
945,416 |
|
- |
|
| Plunkett Matthew |
EVP, Corporate Development |
• – – |
2015-04-06 |
4 |
AS |
$1.86 |
$31,182 |
D/D |
(16,569) |
711,740 |
|
- |
|
| Plunkett Matthew |
EVP, Corporate Development |
• – – |
2015-03-23 |
4 |
AS |
$1.95 |
$116,029 |
D/D |
(59,130) |
728,309 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2015-03-23 |
4 |
AS |
$1.95 |
$341,112 |
D/D |
(175,199) |
3,313,916 |
|
- |
|
| Plunkett Matthew |
EVP, Corporate Development |
• – – |
2015-03-21 |
4 |
D |
$1.94 |
$115,682 |
D/D |
(59,784) |
787,439 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2015-03-21 |
4 |
D |
$1.94 |
$129,134 |
D/D |
(66,736) |
955,416 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2015-03-21 |
4 |
D |
$1.94 |
$24,112 |
D/D |
(12,461) |
3,489,115 |
|
- |
|
| Singer Jack W |
EVP, Global Medical Affairs |
• • – |
2015-03-21 |
4 |
D |
$1.94 |
$181,832 |
D/D |
(93,970) |
1,335,919 |
|
- |
|
| Singer Jack W |
EVP, Global Medical Affairs |
• • – |
2015-03-20 |
4 |
AS |
$1.92 |
$131,125 |
D/D |
(67,600) |
1,429,889 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2015-03-20 |
4 |
AS |
$1.92 |
$122,011 |
D/D |
(63,000) |
1,022,152 |
|
- |
|
| Plunkett Matthew |
EVP, Corporate Development |
• – – |
2015-03-04 |
4 |
AS |
$2.39 |
$28,939 |
D/D |
(12,000) |
847,223 |
|
- |
|
| Singer Jack W |
EVP Global Medical Affairs |
• • – |
2015-02-27 |
4 |
AS |
$2.35 |
$35,251 |
D/D |
(15,000) |
1,497,489 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2015-02-05 |
4 |
AS |
$2.22 |
$22,201 |
D/D |
(10,000) |
1,085,152 |
|
- |
|
| Plunkett Matthew |
EVP, Corporate Development |
• – – |
2015-02-04 |
4 |
AS |
$2.20 |
$26,651 |
D/D |
(12,000) |
859,223 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2015-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
477,255 |
1,095,152 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2015-01-08 |
4 |
AS |
$2.32 |
$23,206 |
D/D |
(10,000) |
617,897 |
|
- |
|
| Plunkett Matthew |
EVP, Corporate Development |
• – – |
2015-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
477,255 |
871,223 |
|
- |
|
| Singer Jack W |
EVP, Global Medical Affairs |
• • – |
2015-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
477,255 |
1,512,489 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2015-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,590,850 |
3,501,576 |
|
- |
|
| Plunkett Matthew |
EVP, Corporate Development |
• – – |
2015-01-05 |
4 |
AS |
$2.34 |
$28,365 |
D/D |
(12,000) |
393,968 |
|
- |
|
229 Records found
|
|
Page 8 of 10 |
|
|
